ORHub Acquires PUR Biologics

ORHub purchased 100% of the equity interest and assets of PUR Biologics.

ORHub will enter the global medical device market using PUR's proprietary technologies to regenerate cartilage, mitigate pain and address the biological causes of degenerative disc disease and joint osteoarthritis.

ORHub is a SaaS-based healthcare data analytics company...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us